Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SERHL2 - GATA3 ectopic expression in 293T cells (dye-swap)
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SERHL2 - Basal-like breast cancer tumors
SERHL2 - NeOAdjuvant Herceptin (NOAH) trial: formalin-fixed, paraffin-embedded breast cancer biopsies
SERHL2 - Molecular apocrine breast tumors
SERHL2 - Prostate cancer
SERHL2 - Metaphase II stage oocytes matured in vivo
SERHL2 - Inflammatory breast cancer: tumor
SERHL2 - Pretreatment breast needle biopsies of locally advanced breast cancer
SERHL2 - Postmenopausal estrogen receptor α-positive breast tumor with PIK3CA mutation
SERHL2 - ER-positive/HER2-negative and ER-negative/HER2-negative breast cancer biopsies (USO-02103 cohort)
SERHL2 - ER-positive/HER2-negative and ER-negative/HER2-negative breast cancer biopsies (MDACC/IGR cohort)
SERHL2 - Inflammatory breast cancer: stroma
SERHL2 - Variable breast cancer tumor sample collection methods
SERHL2 - NOTCH antagonist SAHM1 effect on T-ALL cell lines
SERHL2 - High grade prostate cancer
SERHL2 - Psoriasis lesional and non-lesional skin
SERHL2 - Letrozole effect on breast cancer tumors
SERHL2 - Psoriasis
SERHL2 - Psoriasis response to brodalumab: dose response and time course
SERHL2 - Alcoholic hepatitis
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on